{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T05:09:28Z","timestamp":1740287368705,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007136","name":"Karyopharm Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Royalty Pharma"},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011957","name":"Takeda Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Canc Educ"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Myeloma is the third most common blood cancer and one of the most complex and expensive cancers to treat. Black Americans face health disparities related to myeloma incidence, age at diagnosis, access to novel treatments, and mortality. To help reduce health disparities among Black Americans through education and outreach, the Leukemia &amp; Lymphoma Society has implemented its Myeloma Link initiative. In 2022, a formative, qualitative evaluation was conducted across the 15 U.S. cities that implemented Myeloma Link to better understand the information and communication needs and preferences of three groups: patients, community members, and primary care providers (PCPs). Data collection included interviews with eight patients, two focus groups with a total of ten community members, and interviews with six PCPs. Patients expressed wanting information about treatment experiences, including clinical trials, and emotional and peer support services, particularly from other Black American patients. Community members were largely unfamiliar with myeloma and desired outreach via trusted community organizations about disease signs and symptoms. Both groups discussed the importance of self-advocacy within the current healthcare system and wanted actionable messaging, rather than messaging leading with disparities statistics. PCPs described systemic capacity and time challenges in the context of needing to address more frequently encountered health conditions; nonetheless, PCPs welcomed information and brief trainings about myeloma diagnosis and treatment options, referrals to specialists, and how to improve care, prognosis, and caregiver support. Findings underscore the importance of outreach initiatives such as Myeloma Link to help meet these needs and reduce health disparities.<\/jats:p>","DOI":"10.1007\/s13187-024-02480-3","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T03:16:43Z","timestamp":1723778203000},"page":"124-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding Myeloma-Related Information Needs and Communication Preferences Within Black American Communities: An Exploratory Study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1389-8054","authenticated-orcid":false,"given":"N. S.","family":"Esquivel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Treiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. H.","family":"Husick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ortiz-Ravick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sae-Hau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"DeMairo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Disare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"2480_CR1","unstructured":"Leukemia & Lymphoma Society. 2023. Facts 2022\u20132023. Updated data on blood cancers. https:\/\/www.lls.org\/booklet\/facts-updated-data-blood-cancers Accessed December 10."},{"issue":"10","key":"2480_CR2","doi-asserted-by":"publisher","first-page":"e786","DOI":"10.1016\/S2352-3026(22)00226-5","volume":"9","author":"N Gagelmann","year":"2022","unstructured":"Gagelmann N, Sureda A, Montoto S, Murray J, Bolanos N, Kenyon M, Beksac M, Schonland S, Hayden P, Scheurer H, Morgan K, Garderet L, McLornan DP, Ruggeri A (2022) Access to and affordability of CAR T-cell therapy in multiple myeloma: An EBMT position paper. Lancet Haematology 9(10):e786\u2013e795. https:\/\/doi.org\/10.1016\/S2352-3026(22)00226-5","journal-title":"Lancet Haematology"},{"issue":"12","key":"2480_CR3","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1038\/s41375-021-01250-0","volume":"35","author":"J Corre","year":"2021","unstructured":"Corre J, Perrot A, Hulin C, Caillot D, Stoppa AM, Facon T, Leleu X, Dib M, Karlin Ll, Moreau P, Mohty M, Mariette C, Fontan J, Marolleau J-P, Demarquette H, Slama B, Voillat L, Macro M, Orsini-Piocelle F, Brechignac S, Rey P, Collet P, Tiab M, Belhadj K, Lifermann F, Clement-Filliatre L, Sohn C, Richez V, Avet-Loiseau H, Francophone I, du Myelome IFM (2021) Improved survival in multiple myeloma during the 2005\u20132009 and 2010\u20132014 periods. Leukemia 35(12):3600\u20133603. https:\/\/doi.org\/10.1038\/s41375-021-01250-0","journal-title":"Leukemia"},{"issue":"9","key":"2480_CR4","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/leu.2016.380","volume":"31","author":"R Fonseca","year":"2017","unstructured":"Fonseca R, Abouzaid S, Bonafede M, Cai Q, Parikh K, Cosler L, Richardson P (2017) Trends in overall survival and costs of multiple myeloma, 2000\u20132014. Leukemia 31(9):1915\u20131921. https:\/\/doi.org\/10.1038\/leu.2016.380","journal-title":"Leukemia"},{"issue":"20","key":"2480_CR5","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1182\/bloodadvances.2019000308","volume":"3","author":"S Ailawadhi","year":"2019","unstructured":"Ailawadhi S, Parikh K, Abouzaid S, Zhou Z, Tang W, Clancy Z, Cheung C, Zhou Z-Y, Xie J (2019) Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis. Blood Adv 3(20):2986\u20132994. https:\/\/doi.org\/10.1182\/bloodadvances.2019000308","journal-title":"Blood Adv"},{"issue":"2","key":"2480_CR6","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.jnma.2022.10.001","volume":"115","author":"M Bhutani","year":"2023","unstructured":"Bhutani M, Lonial S, Mikhael J (2023) Disparities in multiple myeloma among African Americans. J Natl Med Assoc 115(2):S26\u2013S31. https:\/\/doi.org\/10.1016\/j.jnma.2022.10.001","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"2480_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-022-00681-x","volume":"12","author":"CS Buradagunta","year":"2022","unstructured":"Buradagunta CS, Garacci Z, D\u2019Souza A, Dhakal B, Devata S, Janz S, Thrift AP, Hari P, Stolley M, Dong J (2022) Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study. Blood Cancer J 12(5):82. https:\/\/doi.org\/10.1038\/s41408-022-00681-x","journal-title":"Blood Cancer J"},{"key":"2480_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1200\/EDBK_238551","volume":"39","author":"S Ganguly","year":"2019","unstructured":"Ganguly S, Mailankody S, Ailawadhi S (2019) Many shades of disparities in myeloma care. Am Soc Clin Oncol Educ Book 39:519\u2013529. https:\/\/doi.org\/10.1200\/EDBK_238551","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"13","key":"2480_CR9","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1080\/10428194.2021.1953013","volume":"62","author":"Al Hadidi","year":"2021","unstructured":"Hadidi Al, Samer DD, Salihu HM, Kamble RT, Lulla P, La Quisa C, Hill GC, Ramos CA, Heslop HE, Usmani SZ (2021) Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study. Leuk Lymphoma 62(13):3256\u20133263. https:\/\/doi.org\/10.1080\/10428194.2021.1953013","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2480_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41408-020-0284-7","volume":"10","author":"CR Marinac","year":"2020","unstructured":"Marinac CR, Ghobrial IM, Birmann BM, Soiffer J, Rebbeck TR (2020) Dissecting racial disparities in multiple myeloma. Blood Cancer J 10(2):19. https:\/\/doi.org\/10.1038\/s41408-020-0284-7","journal-title":"Blood Cancer J"},{"key":"2480_CR11","doi-asserted-by":"publisher","unstructured":"DeSantis, Carol E, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel 2019. Cancer statistics for African Americans, 2019. CA: A Cancer J Clinic 69 (3): 211\u2013233. https:\/\/doi.org\/10.3322\/caac.21555","DOI":"10.3322\/caac.21555"},{"issue":"25","key":"2480_CR12","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","volume":"116","author":"AJ Waxman","year":"2010","unstructured":"Waxman AJ, Mink PJ, Devesa SS, Anderson WF, Weiss BM, Kristinsson SY, McGlynn KA, Landgren O (2010) Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood, J Am Soc Hematol 116(25):5501\u20135506. https:\/\/doi.org\/10.1182\/blood-2010-07-298760","journal-title":"Blood, J Am Soc Hematol"},{"issue":"12","key":"2480_CR13","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1182\/bloodadvances.2021006652","volume":"6","author":"LC Peres","year":"2022","unstructured":"Peres LC, Colin-Leitzinger CM, Teng M, Dutil J, Alugubelli RR, DeAvila G, Teer JK, Dongliang Du, Mo Q, Siegel EM (2022) Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma. Blood Adv 6(12):3767\u20133778. https:\/\/doi.org\/10.1182\/bloodadvances.2021006652","journal-title":"Blood Adv"},{"issue":"8","key":"2480_CR14","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/cncr.31237","volume":"124","author":"Sikander Ailawadhi","year":"2018","unstructured":"Ailawadhi Sikander, Frank Ryan D, Sharma Mayank, Menghani Richa, Temkit M\u2019hamed, Paulus Shumail, Khera Nandita, Hashmi Shahrukh, Advani Pooja, Swaika Abhisek (2018) Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: a comprehensive look at racial disparities. Cancer 124(8):1710\u20131721. https:\/\/doi.org\/10.1002\/cncr.31237","journal-title":"Cancer"},{"issue":"24","key":"2480_CR15","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1182\/blood.2019000406","volume":"133","author":"NR Fillmore","year":"2019","unstructured":"Fillmore NR, Yellapragada SV, Ifeorah C, Mehta A, Cirstea D, White PS, Rivero G, Zimolzak A, Pyarajan S, Do N (2019) With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood J Am Soc Hematology 133(24):2615\u20132618. https:\/\/doi.org\/10.1182\/blood.2019000406","journal-title":"Blood J Am Soc Hematology"},{"issue":"7","key":"2480_CR16","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/cncr.29160","volume":"121","author":"V Bhatnagar","year":"2015","unstructured":"Bhatnagar V, Yin Wu, Goloubeva OG, Ruehle KT, Milliron TE, Harris CG, Rapoport AP, Yanovich S, Sausville EA, Baer MR, Badros AZ (2015) Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study. Cancer 121(7):1064\u20131070. https:\/\/doi.org\/10.1002\/cncr.29160","journal-title":"Cancer"},{"issue":"2","key":"2480_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41408-019-0177-9","volume":"9","author":"Dickran Kazandjian","year":"2019","unstructured":"Kazandjian Dickran, Hill Elizabeth, Hultcrantz Malin, Rustad Evan H, Yellapantula Venkata, Akhlaghi Theresia, Korde Neha, Mailankody Sham, Dew Alex, Papaemmanuil Elli (2019) Molecular underpinnings of clinical disparity patterns in African American vs Caucasian American multiple myeloma patients. Blood Cancer Journal 9(2):15. https:\/\/doi.org\/10.1038\/s41408-019-0177-9","journal-title":"Blood Cancer Journal"},{"key":"2480_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/0147-1767(85)90062-8","volume-title":"Naturalistic inquiry","author":"Y Lincoln","year":"1985","unstructured":"Lincoln Y, Guba E (1985) Naturalistic inquiry. Sage, Beverly Hills, CA"},{"key":"2480_CR19","doi-asserted-by":"publisher","DOI":"10.4324\/9780203793206","volume-title":"Discovery of grounded theory: strategies for qualitative research","author":"B Glaser","year":"2017","unstructured":"Glaser B, Strauss A (2017) Discovery of grounded theory: strategies for qualitative research. Routledge, New York, NY"},{"issue":"1","key":"2480_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pec.2019.08.011","volume":"103","author":"Goerling Ute","year":"2020","unstructured":"Ute Goerling, Faller Hermann, Hornemann Beate, H\u00f6nig Klaus, Bergelt Corinna, Maatouk Imad, Stein Barbara, Teufel Martin, Erim Yesim, Geiser Franziska (2020) Information needs in cancer patients across the disease trajectory A prospective study. Patient Educ Counsel 103(1):120\u2013126. https:\/\/doi.org\/10.1016\/j.pec.2019.08.011","journal-title":"Patient Educ Counsel"},{"issue":"5","key":"2480_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s13187-020-01941-9","volume":"36","author":"E Webb","year":"2021","unstructured":"Webb E, Madeleine EM, Younger ZW, Goodfellow H, Ross J (2021) The supportive care needs of cancer patients: a systematic review. J Cancer Educ 36(5):899\u2013908. https:\/\/doi.org\/10.1007\/s13187-020-01941-9","journal-title":"J Cancer Educ"},{"issue":"2","key":"2480_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s13187-020-01815-0","volume":"37","author":"FT Odedina","year":"2022","unstructured":"Odedina FT, Walsh-Childers K, Young ME, Kaninjing E, Krieger J, Pereira D, Dagne G, Askins N, Fathi P (2022) Development of a minority prostate cancer research digest: communication strategy statement for Black men. J Cancer Educ 37(2):328\u2013337. https:\/\/doi.org\/10.1007\/s13187-020-01815-0","journal-title":"J Cancer Educ"},{"issue":"5","key":"2480_CR23","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1177\/1557988318786669","volume":"12","author":"K Walsh-Childers","year":"2018","unstructured":"Walsh-Childers K, Odedina F, Poitier A, Kaninjing E, Greenberry Taylor III (2018) Choosing channels, sources, and content for communicating prostate cancer information to black men: a systematic review of the literature. Am J Mens Health 12(5):1728\u20131745. https:\/\/doi.org\/10.1177\/1557988318786669","journal-title":"Am J Mens Health"},{"issue":"1","key":"2480_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/hea0001246","volume":"42","author":"O Aspiras","year":"2023","unstructured":"Aspiras O, Lucas T, Thompson HS, Manning MA, Blessman J, Dawadi A, Hirko KA, Penner LA (2023) Culturally targeted message framing and colorectal cancer screening preferences among African Americans. Health Psychol 42(1):1\u20134","journal-title":"Health Psychol"},{"key":"2480_CR25","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1017\/S1463423623000129","volume":"24","author":"GB Black","year":"2023","unstructured":"Black GB, Boswell L, Harris J, Whitaker KL (2023) What causes delays in diagnosing blood cancers? A rapid review of the evidence. Primary Health Care Research & Development 24:e26","journal-title":"Primary Health Care Research & Development"},{"key":"2480_CR26","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1182\/blood-2019-127625","volume":"134","author":"N Ghalehsari","year":"2019","unstructured":"Ghalehsari N, Kancharla P, Nimkar NS, Mazloom A, Ashraf F, Singh A, Goldfinger M (2019) An institutional retrospective study on recognizing the delay in multiple myeloma diagnosis. Blood 134:3430. https:\/\/doi.org\/10.1182\/blood-2019-127625","journal-title":"Blood"}],"container-title":["Journal of Cancer Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-024-02480-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13187-024-02480-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-024-02480-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:11:37Z","timestamp":1740208297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13187-024-02480-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2480"],"URL":"https:\/\/doi.org\/10.1007\/s13187-024-02480-3","relation":{},"ISSN":["0885-8195","1543-0154"],"issn-type":[{"type":"print","value":"0885-8195"},{"type":"electronic","value":"1543-0154"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"19 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}